[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 0.15% 1,332.00 1,331.50 1,332.00 1,333.00 1,318.50 1,327.00 461,932 12:21:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3,335.3 179.9 37.5 35.6 11,711

Smith & Nephew Share Discussion Threads

Showing 1026 to 1049 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
16/9/2021
11:32
Closed my trade for a few shekels, luck to holders.
essentialinvestor
16/9/2021
10:52
oversold imho
marcela9
15/9/2021
23:58
80% discounts in China, make it up in volume?
smcni1968
15/9/2021
16:50
Its in the UK, that's the problem!
ianood
15/9/2021
13:19
Stryker is not showing share price weakness so company specific would think.
essentialinvestor
14/9/2021
15:12
Had a small amount.
essentialinvestor
14/9/2021
11:52
OK Covid protective measures winding down but infections up though looking as though starting to go down but deaths starting to increase -However with restrictions coming off and winter coming very likley (imo)to be an acceration to the upside of both cases hospitalisations and deaths and therefore a decline in elective surgery BAD for SN. https://www.worldometers.info/coronavirus/country/uk/ Use above link if you wish to double check trends -
pugugly
14/9/2021
10:28
A little good news here would be more than welcome given the positive interims. Surely the Company has a fair indication of upswing now as Covid measures wind down. I think it would be prudent to issue an interim t/u in view of the continued share price erosion if only to stop the rot.
luzley
10/9/2021
11:26
I'll take £18 now please. Suet
suetballs
10/9/2021
11:02
BARCLAYS CUTS SMITH & NEPHEW PRICE TARGET TO 1,800 (1,825) PENCE - 'OVERWEIGHT'
philanderer
24/8/2021
19:32
SP has bounced several times from the approx 13.75 type area. Some type of support around there?, not holding atm.
essentialinvestor
24/8/2021
18:58
Today's RNS details shares issued partly in lieu of annual fees. If you read yesterday's RNS, it's yet another director sale.
essentialinvestor
24/8/2021
18:47
What's going on with this share director buys big price goes down.
csalvage
16/8/2021
09:24
I expect we will get increasingly positive updates going forward as pent-up demand escalates and facilities reopen to clear backlogs. American healthcare consumers are not the most patient in the world.
luzley
16/8/2021
09:23
Affluent areas of US are facing much better - that's where most joint surgery is focused.
luzley
16/8/2021
08:25
Ok so no quick profits - but long term I am optimistic. Suet
suetballs
16/8/2021
08:16
Thing is most of their business is in the us where things are getting worse
spoole5
13/8/2021
22:19
Looking to invest here, this seems like a great company with bags of potential for a Covid recovery play. Watching closely.
chard1980
12/8/2021
14:49
H2 guidance is predicated on normalisation of the COVID pandemic in their major markets. Now currently we have the COVID situation in the US rapidly deteriorating- hopefully that may peak within the next few weeks. May be that is discounted at the current share price level, or someone else will see longer term value and make an offer for the Company. Ian, interesting re the epidural, these days they are far more cautious using GA. Back in the day you were often put under general for even minor surgery.
essentialinvestor
12/8/2021
14:39
Keyno, you’re right. I got fed up waiting for someone to make some enlightened comment that would put some life into this board, hopefully I’ve done that. Now make some comment on what I said about +37% to +49% that’s constructive !
basildublin
12/8/2021
13:23
Basil has only been on ADVFN since yesterday.
keyno
12/8/2021
11:49
Bought a few today. Gotta b cheap.
its the oxman
12/8/2021
10:49
Ian, when S&N say the numbers are the correct interpretation of the guidance it gives a certain validity to the figures.
basildublin
12/8/2021
10:49
Ian, when S&N say the numbers are the correct interpretation of the guidance it gives a certain validity to the figures.
basildublin
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
ADVFN Advertorial
Your Recent History
LSE
SN.
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210928 11:37:17